Skip to main content
Jessica Liegel, MD, Hematology, Boston, MA, Beth Israel Deaconess Medical Center

JessicaJayneLiegelMD

Hematology Boston, MA

Hematologic Oncology

Instructor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Dr. Liegel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Liegel's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine/Pediatrics, 2008 - 2012
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 2008

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2014 - 2025
  • MN State Medical License
    MN State Medical License 2012 - 2018
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • CD155-Tigit Pathway Modulation in Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine Model
    Jessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma
    Jessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematologi...
    Jessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/2019

Lectures

  • T Cells Educated By DC/AML Fusions in the Context of 4-1BB Costimulation As a Potent Strategy for Adoptive Cellular Therapy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Transcriptome Sequencing Demonstrates Unique Signature Associated with Durable Clinical Response to DC/AML Fusion Vaccine 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • A Novel Monoclonal Antibody Combination Plus DC/AML Fusion Vaccine Eradicates AML in an Immunocompetent Murine Model 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations